Azenta Refocuses Genomics Strategy Following Major Technology Divestiture
Life sciences firm Azenta is recalibrating its market position and financial outlook after offloading key genomic assets in a high-profile transaction.
Category
Search Results for
Latest stories, in-depth analysis & breaking updates
1+
Articles
